Open AccessRheumatoid arthritis patients show different levels of pro-inflammatory chemokine-cleaving enzyme CD26 on T cells, depending on the therapy
Author(s) -
Oscar J. Cordero,
Calvi�o Cristina,
Varela Rub�n,
L�pez-Gonz�lez Tania,
Vinuela Juan,
Mouri�o Coral,
De Aspe De La Iglesia Bruno,
Rodr�guez-L�pez Marina,
Del Campo-P�rez Victor,
P. M. van Putten Jos
Publication year - 2013
Publication title -
frontiers in immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.646
H-Index - 124
ISSN - 1664-3224
DOI - 10.3389/conf.fimmu.2013.02.01018
Subject(s) - dipeptidyl peptidase , medicine , rheumatoid arthritis , chemokine , proinflammatory cytokine , immune system , immunology , stromal cell , arthritis , ccl5 , t cell , inflammation , enzyme , biology , biochemistry , il 2 receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom